Number of Shares
650,000.00
Current Holdings Value*
$6.58 Mil
% of Portfolio
3.29%
Total Estimate Gain
$189,800.00
% of Total Estimate Gain
2.89%

HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition Corp Holding Summary

As of 2025-03-31, HEIGHTS CAPITAL MANAGEMENT, INC held 650,000.00 shares of Drugs Made In America Acquisition Corp(DMAAU), totaling $6.58 Mil. This investment constitutes 3.29% of their stock portfolio, and HEIGHTS CAPITAL MANAGEMENT, INC now holds -% of the outstanding Drugs Made In America Acquisition Corp(DMAAU) stock.

The initial trade took place in 2025Q1. And since then HEIGHTS CAPITAL MANAGEMENT, INC has made 1 purchases of DMAAU, at an average price of $10.09, for a total of 650,000.00 shares. Based on historical transaction data and DMAAU's current price of $10.38, HEIGHTS CAPITAL MANAGEMENT, INC's estimated gain on his DMAAU holdings is $189,800.00, reflecting a 2.89% gain to date.

HEIGHTS CAPITAL MANAGEMENT, INC DMAAU ($10.38) Holding Chart

HEIGHTS CAPITAL MANAGEMENT, INC DMAAU ($10.38) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1